A belief is faith based and not a self evident truth. Looking at what top20 hold (40%) and exuberant outgoings each quarter with only really a concept cream was enough evidence that it was not worth investing in at 90-300mill$ with no income or deals in place. And not to mention the salaries being paid with no income. Maybe it has a chance later after successful clinical trials. But how this company manages and justifies the money spent each quarter is questionable imo.
Hopefully turns around with successful clinical trials for holders as imo it is a tough time for everyone in every stock they hold. Not just bot.
Ann: Botanix Announces Top Line BTX 1204 Atopic Dermatitis Data, page-86
-
- There are more pages in this discussion • 126 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.5¢ |
Change
-0.010(2.82%) |
Mkt cap ! $627.0M | |||
| Open | High | Low | Value | Volume |
| 35.0¢ | 35.3¢ | 34.5¢ | $582.2K | 1.679M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 32454 | 34.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.0¢ | 210000 | 3 |
View Market Depth
| Last trade - 16.10pm 01/11/2024 (20 minute delay) ? |
| BOT (ASX) Chart |